 Heres a roundup of top developments in the biotech space over the last 24 hours.None of the NYSE- or Nasdaq-listed biotech stocks hit 52 week highs Thursday.Down In The Dumps Biotech Stocks Hitting 52-week lows on March 26 Aptevo Therapeutics Inc NASDAQ: APVO reacted to its fourth-quarter 